AI assistant
Sending…
NovoCure Ltd — Director's Dealing 2015
Oct 6, 2015
31949_dirs_2015-10-06_a108dfcb-3a17-4536-b301-98217d805e24.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2015-10-05
Reporting Person: DOYLE WILLIAM F (Director, 10% Owner)
Reporting Person: WFD Ventures Fund II, L.P. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-10-05 | Ordinary Shares | X | 399659 | $3.54 | Acquired | 1380874 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-10-05 | Warrants | $3.54 | X | 399659 | Disposed | 2015-10-11 | Ordinary Shares (399659) | Indirect |
Footnotes
F1: Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II, LLC, which is the general partner of WFD Ventures Fund II. Mr. Doyle possesses sole voting and investment power over shares owned by WFD Ventures Fund II (subject to certain rights of the advisory board of WFD Ventures Fund II to approve sales of any of the shares owned by WFD Ventures Fund II).
F2: Currently exercisable as of the date hereof.
More from NovoCure Ltd
Proxy Solicitation & Information Statement
2026
May 21
Earnings Release
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Board/Management Information
2026
Apr 24
Board/Management Information
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3